4-ring imidazole derivatives as modulators of metabotropic glutamate receptor5

Details for Australian Patent Application No. 2004225887 (hide)

Owner Merck & Co., Inc.

Inventors Huang, Dehua; Hu, Essa Hsinyi; Cosford, Nicholas D. P.; Smith, Nicholas D.

Agent Spruson & Ferguson

Pub. Number AU-A-2004225887

PCT Pub. Number WO2004/087653

Priority 60/460,029 03.04.03 US

Filing date 30 March 2004

Wipo publication date 14 October 2004

International Classifications

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/087653 Priority application(s): WO2004/087653

28 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004225894-Container

2004225886-A process for the preparation of fludarabine phosphate from 2-fluoroadenine and fludarabine phosphate salts with amines or ammonia